Impact of ligand protonation on virtual screening against β-secretase (BACE1)

Structure-based virtual screens were carried out against β-secretase (BACE1) to investigate the impact of ligand protonation on screening efficacy. A comparative evaluation of the performance and its dependence on ligand protonation states docking by Surflex, eHiTS, GOLD, and FlexX-Pharm was performed. Virtual screening performed by FlexX-Pharm (EF(1%)=69) and Surflex (EF(1%)=58) provided the best efficiency. Screening protocols by FlexX-Pharm and GOLD were affected by ligand protonation, while performance of Surflex did not depend on ligand protonation.

 

Tímea Polgár, Csaba Magyar, István Simon, György M. Keserü
November 1, 2007
Learn More
LinkedIn